Advertisement
Advertisement

SNDX

SNDX logo

Syndax Pharmaceuticals, Inc.

9.91
USD
-0.08
-0.84%
Jul 31, 16:00 UTC -4
Closed
exchange

After-Market

9.93

+0.02
+0.24%

Syndax Pharmaceuticals, Inc. Profile

Info & Links

CEO

Michael A. Metzger

Headquarters

730 Third Avenue, 9th Floor
New York, NY 10017, UNITED STATES

Sector

Medical

Auditor

Deloitte & Touche LLP

Share holders

11

Employees

270

Syndax Pharmaceuticals, Inc. Statistics

Valuation Measures

Market Capitalization2

854.45M

Enterprise Value

1.04B

Enterprise Value/EBITDA(ttm)

-2.92

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

96.21%

Operating Margin(ttm)

--

Profit Margin(ttm)

-1066.79%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

-69.40%

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

43.72M

Revenue Per Share(ttm)

0.51

Gross Profit(ttm)

42.01M

EBITDA(ttm)3

-357.01M

Net Income Available to Common(ttm)

-331.20M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

--

52-Week Change

-55.80%

S&P 500 52-Week Change

14.80%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

86.05M

Dividend Yield

--

Float4

--

% Held by Insiders

--

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

516.31M

Total Cash Per Share(mrq)

6.00

Total Debt(mrq)

343.80M

Total Debt/Equity(mrq)

159.86%

Current Ratio(mrq)

5.80%

Quick Ratio(mrq)

--

Book Value Per Share(mrq)

2.50

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.10

Free Cash Flow(ytd)

-95.16M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement